T\u00fcrkiye\u2019nin d\u00f6rt bir yan\u0131ndan \u00e7ocuk onkolojisi uzmanlar\u0131n\u0131 bir araya getiren “N\u00f6roblastom 2025 Sempozyumu”, \u0130zmir \u00c7e\u015fme\u2019de ger\u00e7ekle\u015ftirildi. Prof. Dr. Hatice Nur Olgun, N\u00f6roblastom protokollerinin uygulanmas\u0131ndan \u00f6nce y\u00fcksek riskli grupta be\u015f y\u0131ll\u0131k sa\u011fkal\u0131m oranlar\u0131n\u0131n y\u00fczde 6-8 seviyelerinde oldu\u011funu, 2020 Protokol\u00fc ile bu oran\u0131n y\u00fczde 65\u2019e y\u00fckseldi\u011fini s\u00f6yledi.
\n
Ac\u0131badem Kent Hastanesi ev sahipli\u011finde, T\u00fcrk Pediatrik Onkoloji Grubu (TPOG) ve T\u00fcrk Kanser Ara\u015ft\u0131rma ve Sava\u015f Kurumu Derne\u011fi \u0130zmir \u015eubesi i\u015f birli\u011fiyle \u00c7e\u015fme Il\u0131ca Otel\u2019de ger\u00e7ekle\u015ftirilen toplant\u0131n\u0131n ana g\u00fcndemi, \u00e7ocukluk \u00e7a\u011f\u0131 N\u00f6roblastom tedavisinde standartlar\u0131 g\u00fcncellemeyi hedefleyen TPOG N\u00f6roblastom 2026 Protokol\u00fc oldu. Sempozyum ba\u015fkanl\u0131\u011f\u0131n\u0131 y\u00fcr\u00fcten Ac\u0131badem Kent Onkoloji Merkezi Pediatrik Onkoloji B\u00f6l\u00fcm\u00fc Sorumlusu Prof. Dr. Hatice Nur Olgun, yeni protokol\u00fcn T\u00fcrkiye genelindeki pediatrik onkoloji uzmanlar\u0131n\u0131n katk\u0131lar\u0131yla olu\u015fturuldu\u011funu belirterek, \u00e7al\u0131\u015fman\u0131n tedavi yan\u0131tlar\u0131n\u0131n daha hassas de\u011ferlendirilmesini ve \u00f6zellikle y\u00fcksek riskli hastalarda sa\u011fkal\u0131m oranlar\u0131n\u0131n art\u0131r\u0131lmas\u0131n\u0131 ama\u00e7lad\u0131\u011f\u0131n\u0131 s\u00f6yledi. \u0130statistiki bilgi veren Prof. Dr. Olgun, T\u00fcrkiye\u2019de \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinin t\u00fcm kanserlerin y\u00fczde 2-3\u2019\u00fcn\u00fc olu\u015fturdu\u011funa dikkat \u00e7ekti. Her y\u0131l yakla\u015f\u0131k 3.000-4.000 \u00e7ocu\u011fa yeni kanser tan\u0131s\u0131 kondu\u011funu kaydeden Olgun, N\u00f6roblastomun “\u00e7ocuk onkolojisinin en k\u00f6t\u00fc seyirli t\u00fcm\u00f6rlerinden biri” oldu\u011funu, hastalar\u0131n \u00e7o\u011funun sinsi ilerleyi\u015f nedeniyle ileri evrede tan\u0131 ald\u0131\u011f\u0131n\u0131 aktard\u0131.<\/p>\n
2020 protokol\u00fcyle ile gelen tedavi ba\u015far\u0131s\u0131
\n
N\u00f6roblastom protokollerinin uygulanmas\u0131ndan \u00f6nce y\u00fcksek riskli grupta be\u015f y\u0131ll\u0131k sa\u011fkal\u0131m oranlar\u0131n\u0131n y\u00fczde 6-8 seviyelerinde oldu\u011funu, 2020 Protokol\u00fc ile bu oran\u0131n y\u00fczde 65\u2019e y\u00fckseldi\u011fini s\u00f6yleyen Prof. Dr. Olgun, “Bu ba\u015far\u0131n\u0131n, \u00fclkemizde y\u00fcr\u00fct\u00fclen \u00e7ok merkezli i\u015f birli\u011fi, standart tedavi yakla\u015f\u0131mlar\u0131n\u0131n benimsenmesi ve ortak veri payla\u015f\u0131m k\u00fclt\u00fcr\u00fcn\u00fcn g\u00fc\u00e7lenmesiyle elde ediliyor. Yeni protokol\u00fcn her a\u015famas\u0131 ortak ak\u0131lla ve g\u00f6n\u00fclden katk\u0131larla \u015fekilleniyor. Her payla\u015f\u0131m, her \u00f6neri, bir \u00e7ocu\u011fun ya\u015fam\u0131na dokunuyor. Bu birliktelik, \u00fclkemizde \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinde elde etti\u011fimiz ilerlemenin en de\u011ferli g\u00f6stergesidir.” dedi.<\/p>\n
33 y\u0131ll\u0131k birikimin sonu\u00e7lar\u0131
\n
T\u00fcrkiye\u2019nin SIOPEN (Avrupa Pediatrik Onkoloji N\u00f6roblastom Grubu) temsilcisi de olan Prof. Dr. Olgun, 33 y\u0131l \u00f6nce Ege B\u00f6lgesi\u2019ndeki d\u00f6rt hastaneyle ba\u015flayan N\u00f6roblastom protokol\u00fc \u00e7al\u0131\u015fmalar\u0131n\u0131n bug\u00fcn ulusal d\u00fczeyde tedavi standard\u0131n\u0131n temelini olu\u015fturdu\u011funu ifade etti. Olgun, N\u00f6roblastom protokollerinin uygulanmas\u0131ndan \u00f6nce y\u00fcksek riskli grupta be\u015f y\u0131ll\u0131k sa\u011fkal\u0131m oranlar\u0131n\u0131n y\u00fczde 10\u2019u bile bulmad\u0131\u011f\u0131n\u0131, TPOG N\u00f6roblastom 2020 Protokol\u00fc ile bu oran\u0131n 65\u2019e ula\u015ft\u0131\u011f\u0131n\u0131 kaydetti. Olgun, bu ba\u015far\u0131n\u0131n, \u00e7ok merkezli i\u015f birli\u011fi, tedavi yakla\u015f\u0131mlar\u0131n\u0131n standardizasyonu ve ortak veri payla\u015f\u0131m\u0131n\u0131n g\u00fc\u00e7lenmesiyle sa\u011fland\u0131\u011f\u0131n\u0131 ifade ederken, “Yeni protokollerde molek\u00fcler genetik incelemeler, imm\u00fcnoterapi ve hedefe y\u00f6nelik tedavilerin yer almas\u0131, sa\u011fkal\u0131m oranlar\u0131n\u0131n uluslararas\u0131 d\u00fczeylere ula\u015fmas\u0131nda kritik rol oynayacak.” ifadelerini kulland\u0131.<\/p>\n
\u0130ki g\u00fcn s\u00fcren sempozyum boyunca klinik ara\u015ft\u0131rmalardan cerrahi yakla\u015f\u0131mlara, radyolojik ve molek\u00fcler tan\u0131 y\u00f6ntemlerinden relaps ve refrakter hastal\u0131k tedavilerine kadar geni\u015f bir yelpazede sunumlar yap\u0131ld\u0131. Akademisyenler, hekimler, hem\u015fireler ve ara\u015ft\u0131rmac\u0131lar, N\u00f6roblastom\u2019un tan\u0131 ve tedavi s\u00fcre\u00e7lerini geli\u015ftirmek i\u00e7in bilgi ve deneyimlerini payla\u015ft\u0131. T\u00fcrkiye\u2019de \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinin tedavisinde ulusal i\u015f birli\u011fi ve bilimsel dayan\u0131\u015fman\u0131n \u00f6nemini bir kez daha ortaya koyan toplant\u0131n\u0131n kapan\u0131\u015f\u0131nda de\u011ferlendirmelerde bulunan Prof. Dr. Olgun, “Her katk\u0131, bir \u00e7ocu\u011fun ya\u015fam\u0131na umut kat\u0131yor. Yeni protokol\u00fcn her a\u015famas\u0131 ortak ak\u0131lla \u015fekilleniyor. Bu birliktelik, \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinde elde etti\u011fimiz ilerlemenin en de\u011ferli g\u00f6stergesi” diye ekledi.
<\/p>\n","protected":false},"excerpt":{"rendered":"
T\u00fcrkiye\u2019nin d\u00f6rt bir yan\u0131ndan \u00e7ocuk onkolojisi uzmanlar\u0131n\u0131 bir araya getiren “N\u00f6roblastom 2025 Sempozyumu”, \u0130zmir \u00c7e\u015fme\u2019de ger\u00e7ekle\u015ftirildi. Prof. Dr. Hatice Nur Olgun, N\u00f6roblastom protokollerinin uygulanmas\u0131ndan \u00f6nce y\u00fcksek riskli grupta be\u015f y\u0131ll\u0131k sa\u011fkal\u0131m oranlar\u0131n\u0131n y\u00fczde 6-8 seviyelerinde oldu\u011funu, 2020 Protokol\u00fc ile bu oran\u0131n y\u00fczde 65\u2019e y\u00fckseldi\u011fini s\u00f6yledi. Ac\u0131badem Kent Hastanesi ev sahipli\u011finde, T\u00fcrk Pediatrik Onkoloji Grubu (TPOG)…<\/p>\n","protected":false},"author":1,"featured_media":74096,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-74095","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/74095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=74095"}],"version-history":[{"count":1,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/74095\/revisions"}],"predecessor-version":[{"id":74097,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/74095\/revisions\/74097"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/media\/74096"}],"wp:attachment":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=74095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=74095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=74095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}